Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheumatol. 2014 Feb; 66(2):379-89.
View in:
PubMed
subject areas
Abatacept
Abatacept
Adult
Adult
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Double-Blind Method
Double-Blind Method
Female
Female
Humans
Humans
Immunoconjugates
Immunoconjugates
Immunosuppressive Agents
Immunosuppressive Agents
Internationality
Internationality
Longitudinal Studies
Longitudinal Studies
Lupus Nephritis
Lupus Nephritis
Male
Male
Severity of Illness Index
Severity of Illness Index
Treatment Outcome
Treatment Outcome
authors with profiles
Joan Merrill